Stay updated on GVAX & Pembrolizumab in MMR-p CRC Clinical Trial
Sign up to get notified when there's something new on the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page.

Latest updates to the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page
- Check5 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.3, indicating an update to the page framework.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe revision label at the bottom of the page was updated from v3.5.4 to v3.5.5, indicating a minor update to the page's version metadata. No study content or data appears to have been altered.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page’s revision was updated from v3.5.3 to v3.5.4, indicating a newer build of the entry. This update seems to be a metadata/version change rather than a modification to study details or visible content.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page’s footer revision/version indicator has been updated from v3.5.0 to v3.5.3, reflecting a website/UI release rather than a modification to the study record content.SummaryDifference0.1%

- Check106 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check121 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

Stay in the know with updates to GVAX & Pembrolizumab in MMR-p CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page.